Ajith Anagha Kollamparambil, Subramani Sasikala, Manickam Agaath Hedina, Ramasamy Sivasamy
Molecular Genetics and Cancer Biology Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore-641 046.
Adv Pharm Bull. 2022 Aug;12(4):649-657. doi: 10.34172/apb.2022.048. Epub 2021 May 30.
Cancer is the leading challenge to human health since the dawn of early Egyptian manuscripts, where they found tumour from fossils in the modernized 20th century. Increasing rate of incidence and death from cancer in the past few years is thought provoking. Among all type of cancers, breast cancer is very common among women and diverse in character. Drug resistance is the challenging aspect for traditional chemotherapy. Data was collected from online platform without any time restriction. After screening and evaluation, 66 articles were considered for this study. This review is a summarized collection of information from published studies on human genes associated with drug resistance in breast cancer treatment. Analysis of these findings highlights the importance of MAP kinase and ABC gene families in creating resistance barriers. Genes involved in cell cycle alteration, apoptosis, and hippo pathway were also linked with drug resistance particularly in breast cancer. The exact mechanism of chemotherapy resistance is still unresolved and unexplained the drug resistance seen in breast cancer patients were multifactorial. Drug induced up regulation or down regulation of genes contributes unusual protein expression and ultimately leads to resistance. The ultimate focus of this review is to identify the genes having pivotal role in chemotherapy resistance in breast cancer.
自早期埃及手稿时代起,癌症就一直是人类健康面临的主要挑战,在20世纪现代化进程中,人们从化石中发现了肿瘤。过去几年中,癌症发病率和死亡率的上升令人深思。在所有癌症类型中,乳腺癌在女性中非常常见且具有多样性。耐药性是传统化疗面临的挑战。数据从在线平台收集,没有时间限制。经过筛选和评估,本研究纳入了66篇文章。本综述总结了已发表的关于乳腺癌治疗中与耐药性相关的人类基因研究的信息。对这些研究结果的分析突出了丝裂原活化蛋白激酶(MAP)和ABC基因家族在形成耐药屏障中的重要性。参与细胞周期改变、凋亡和河马通路的基因也与耐药性有关,尤其是在乳腺癌中。化疗耐药的确切机制仍未解决,乳腺癌患者中出现的耐药性是多因素的。药物诱导的基因上调或下调导致异常蛋白质表达,最终导致耐药。本综述的最终重点是确定在乳腺癌化疗耐药中起关键作用的基因。